Anti-Human CD307e (FcRL5) - PE
| Code | Size | Price |
|---|
| LEI-I-1222-100ug | 100 ug | £303.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Isotype: IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: 509F6
Regulatory Status: RUO
Target Species: Human
Applications:
- Blocking
- Flow Cytometry
- Immunoprecipitation (IP)
Shipping:
2-8°C
Storage:
This R-phycoerythrin (R-PE) conjugate is stable when stored at 2-8°C. Do not freeze.
Further Information
Antigen Distribution:
FcRL5 is expressed on mature B cells and plasma cells.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
R-phycoerythrin (PE)
Format:
This R-phycoerythrin (R-PE) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This R-phycoerythrin (R-PE) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
Cells transfected with Human FcRL5.
Long Description:
FcRL5 antibody, 509F6, recognizes Fc receptor-like 5 (FcRL5), also known as immunoglobulin superfamily receptor translocation associated 2 (IRTA2), Fc receptor homolog 5 (FcRH5), and BXMAS1. FcRL5 is a 106 kDa type I transmembrane glycoprotein containing 9 Ig-like extracellular domains, a cytoplasmic ITAM-like consensus sequence, and two cytoplasmic ITIM-like sequences1. FcRL5 is found on most mature B cells, with the highest levels on naive and memory B cells and plasma cells1,2. FcRL5 is an IgG receptor and binds to all IgG isotypes3, resulting in the inhibition of BCR signaling through the recruitment of SH2 domain-containing tyrosine phosphatase 1 (SHP-1) after tyrosine phosphorylation of its two ITIMs4. B cell malignancies, including multiple myeloma, chronic lymphocytic leukemia, mantle cell lymphoma, and hairy cell leukemia, often exhibit aberrant FCRL5 expression, indicating FcRL5 as a potential biomarker or therapeutic target5-7.
NCBI Gene:
83416
Target:
FcRL5
References
1. M. D. Cooper., et al. (2001). Proc. Natl. Acad. Sci. USA 98: 9772?9777
2. Koeppen H., et al. (2006) Int Immunol. 18:1363-1373
3. Colonna M., et al. (2012) J Immunol. 188(10):4741-5
4. M. D. Cooper., et al (2007) Proc. Natl. Acad. Sci. USA 104: 9770?9775
5. Dalla-Favera R., et al. (2001) Immunity. 14(3):277-89
6. Pastan I., et al. (2007) Leukemia. 21(1):169-74
7. Nagata S., et al. (2005) Clin Cancer Res. 11(1):87-96
Related Products
| Product Name | Product Code | Supplier | Mouse IgG2a Isotype Control - Purified in vivo GOLD™ Functional Grade | LEI-I-118 | Leinco Technologies | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human CD307e (FcRL5) - Purified in vivo GOLD™ Functional Grade | LEI-I-1220 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anti-Human CD307e (FcRL5) - Purified in vivo PLATINUM™ Functional Grade | LEI-I-2100 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mouse IgG2a Isotype Control - Purified in vivo PLATINUM™ Functional Grade | LEI-P381 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||